S11.3 Low-dose interleukin-2 therapy in active systemic lupus erythematosus (lupil-2): a multi-center, double-blind, randomized and placebo-controlled phase 2 trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.